Brandon M. Meyers

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 26, 2026

So Long, Olden Days.

So Long, Olden Days.

Journal: International journal of radiation oncology, biology, physics

Published: October 16, 2025

Resectable locally advanced head and neck squamous cell carcinoma: cut first or immune checkpoint inhibitors first?

Resectable locally advanced head and neck squamous cell carcinoma: cut first or immune checkpoint inhibitors first?

Journal: Oral oncology

Published: September 16, 2025

Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen.

Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen.

Journal: Future science OA

Published: August 28, 2025

Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience.

Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience.

Journal: Immunotherapy

Published: June 13, 2025

Induction chemotherapy and immunotherapy followed by chemo-radiotherapy in incurable advanced head and neck squamous cell carcinoma: A case-series.

Induction chemotherapy and immunotherapy followed by chemo-radiotherapy in incurable advanced head and neck squamous cell carcinoma: A case-series.

Journal: Oral oncology

Published: May 14, 2025

DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.

DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.

Journal: Nature communications

Published: April 15, 2025

Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma.

Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma.

Journal: Therapeutic advances in medical oncology

Published: February 26, 2025

Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis.

Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis.

Journal: Immunotherapy

Published: December 06, 2024

Impact of Wait Time From Preoperative CT to Pancreatectomy on Overall Survival for Patients With Pancreatic Carcinoma.

Impact of Wait Time From Preoperative CT to Pancreatectomy on Overall Survival for Patients With Pancreatic Carcinoma.

Journal: Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes

Published: September 06, 2024

Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma.

Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: August 09, 2024

Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.

Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.

Journal: Cancers

Published: July 02, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026